Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies

Identifieur interne : 003C70 ( Main/Exploration ); précédent : 003C69; suivant : 003C71

Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies

Auteurs : Michael S. Okun [États-Unis] ; Jerrold L. Vitek [États-Unis]

Source :

RBID : ISTEX:E682B594021E2604FC4ED081E4EC46DC70B8D830

Descripteurs français

English descriptors

Abstract

An analysis of the international literature on lesioning for movement disorders was undertaken to review lesion therapy for Parkinson's disease (PD) and other movement disorders and to highlight important controversies surrounding this surgical technique. Lesions have been placed throughout the neuraxis with varying approaches and success. Our understanding of the pathophysiological basis underlying the development of PD and other movement disorders has led to a better understanding of why lesioning certain portions of the nervous system should improve motor function. Advances in imaging technology and electrophysiological techniques used for localization of brain structures, such as microelectrode mapping, have improved the ability to accurately identify and lesion target structures deep in the brain. This improvement has led to an increase in the degree and consistency of clinical benefit. The major controversies in lesion therapy include: (1) which target for which disorder; (2) determination of the optimal lesion site and whether the external globus pallidus (GPe) should be included in the pallidotomy lesion for PD; (3) determination of the size of the lesion; (4) whether bilateral lesions can be placed without the high incidence of side effects reported by some investigators; (5) whether microelectrodes aid in the ability to improve clinical outcomes or increase the risk of side effects by making multiple microelectrode penetrations; (6) whether the subthalamic nucleus (STN) should be explored further as a lesioning target; and (7) whether lesioning should be abandoned entirely in favor of deep brain stimulation (DBS). Many important questions and controversies regarding lesion therapy remain unanswered. It is unlikely given the pro‐DBS environment that these questions will be answered in the near future. We should, however, be careful not to abandon an effective therapy before fully exploring through randomized trials the relative effect of different surgical approaches for the treatment of patients with movement disorders. © 2004 Movement Disorder Society

Url:
DOI: 10.1002/mds.20037


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies</title>
<author>
<name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
</author>
<author>
<name sortKey="Vitek, Jerrold L" sort="Vitek, Jerrold L" uniqKey="Vitek J" first="Jerrold L." last="Vitek">Jerrold L. Vitek</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E682B594021E2604FC4ED081E4EC46DC70B8D830</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20037</idno>
<idno type="url">https://api.istex.fr/document/E682B594021E2604FC4ED081E4EC46DC70B8D830/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000144</idno>
<idno type="wicri:Area/Istex/Curation">000144</idno>
<idno type="wicri:Area/Istex/Checkpoint">002651</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Okun M:lesion:therapy:for</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15077235</idno>
<idno type="wicri:Area/PubMed/Corpus">003494</idno>
<idno type="wicri:Area/PubMed/Curation">003494</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003422</idno>
<idno type="wicri:Area/Ncbi/Merge">000D90</idno>
<idno type="wicri:Area/Ncbi/Curation">000D90</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D90</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Okun M:lesion:therapy:for</idno>
<idno type="wicri:Area/Main/Merge">005628</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0262287</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002201</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B20</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002114</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Okun M:lesion:therapy:for</idno>
<idno type="wicri:Area/Main/Merge">005952</idno>
<idno type="wicri:Area/Main/Curation">003C70</idno>
<idno type="wicri:Area/Main/Exploration">003C70</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies</title>
<author>
<name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Neurosurgery, University of Florida, Gainesville, Florida</wicri:regionArea>
<placeName>
<region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Vitek, Jerrold L" sort="Vitek, Jerrold L" uniqKey="Vitek J" first="Jerrold L." last="Vitek">Jerrold L. Vitek</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Emory University, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-04">2004-04</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="375">375</biblScope>
<biblScope unit="page" to="389">389</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E682B594021E2604FC4ED081E4EC46DC70B8D830</idno>
<idno type="DOI">10.1002/mds.20037</idno>
<idno type="ArticleID">MDS20037</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Electric Stimulation Therapy (instrumentation)</term>
<term>Globus Pallidus (surgery)</term>
<term>Humans</term>
<term>Lesion therapy</term>
<term>Microelectrodes</term>
<term>Movement Disorders (epidemiology)</term>
<term>Nervous system diseases</term>
<term>Neurosurgical Procedures (instrumentation)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Subthalamic Nucleus (surgery)</term>
<term>Thalamus (surgery)</term>
<term>Therapy</term>
<term>Treatment</term>
<term>deep brain stimulation</term>
<term>pallidotomy</term>
<term>thalamotomy</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Movement Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en">
<term>Electric Stimulation Therapy</term>
<term>Neurosurgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Globus Pallidus</term>
<term>Subthalamic Nucleus</term>
<term>Thalamus</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Microelectrodes</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Système nerveux pathologie</term>
<term>Thérapie</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An analysis of the international literature on lesioning for movement disorders was undertaken to review lesion therapy for Parkinson's disease (PD) and other movement disorders and to highlight important controversies surrounding this surgical technique. Lesions have been placed throughout the neuraxis with varying approaches and success. Our understanding of the pathophysiological basis underlying the development of PD and other movement disorders has led to a better understanding of why lesioning certain portions of the nervous system should improve motor function. Advances in imaging technology and electrophysiological techniques used for localization of brain structures, such as microelectrode mapping, have improved the ability to accurately identify and lesion target structures deep in the brain. This improvement has led to an increase in the degree and consistency of clinical benefit. The major controversies in lesion therapy include: (1) which target for which disorder; (2) determination of the optimal lesion site and whether the external globus pallidus (GPe) should be included in the pallidotomy lesion for PD; (3) determination of the size of the lesion; (4) whether bilateral lesions can be placed without the high incidence of side effects reported by some investigators; (5) whether microelectrodes aid in the ability to improve clinical outcomes or increase the risk of side effects by making multiple microelectrode penetrations; (6) whether the subthalamic nucleus (STN) should be explored further as a lesioning target; and (7) whether lesioning should be abandoned entirely in favor of deep brain stimulation (DBS). Many important questions and controversies regarding lesion therapy remain unanswered. It is unlikely given the pro‐DBS environment that these questions will be answered in the near future. We should, however, be careful not to abandon an effective therapy before fully exploring through randomized trials the relative effect of different surgical approaches for the treatment of patients with movement disorders. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Floride</li>
<li>Géorgie (États-Unis)</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Floride">
<name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
</region>
<name sortKey="Vitek, Jerrold L" sort="Vitek, Jerrold L" uniqKey="Vitek J" first="Jerrold L." last="Vitek">Jerrold L. Vitek</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C70 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C70 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E682B594021E2604FC4ED081E4EC46DC70B8D830
   |texte=   Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024